Artículo
Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021
Pisapia, Pasquale; Costa, José Luis; Pepe, Francesco; Russo, Gianluca; Gragnano, Gianluca; Russo, Alessandro; Iaccarino, Antonino; Miguel Pérez, Diego de; Serrano, Maria Josè; Denninghoff, Valeria Cecilia
; Quagliata, Luca; Rolfo, Christian; Malapelle, Umberto
![Icon](/themes/CONICETDigital/images/conicet.png)
Fecha de publicación:
05/2021
Editorial:
Elsevier
Revista:
Critical Reviews In Oncology Hematology
ISSN:
1040-8428
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Lung cancer is the leading cause of cancer death worldwide, with non-small cell lung cancer (NSCLC) representing its most commonly diagnosed sub-type. Despite the significant improvements in lung cancer biomarkers knowledge, accompanied by substantial technological advances in molecular tumor profiling, a considerable fraction (up to 30 %) of advanced NSCLC patient presents with major testing challenges or tissue unavailability for molecular analysis. In this context, liquid biopsy is on the rise, currently gaining considerable interest within the molecular pathology and oncology community. Molecular profiling of liquid biopsy specimens using next generation molecular biology methodologies is a rapidly evolving field with promising applications not exclusively limited to advanced stages but also more recently expanding to early stages cancer patients. Here, we offer an overview of some of the most consolidated and emerging applications of next generation sequencing technologies for liquid biopsy testing in NSCLC.
Palabras clave:
EARLY DETECTION
,
LIQUID BIOPSY
,
NGS
,
NSCLC
,
SCREENING
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(SEDE CENTRAL)
Articulos de SEDE CENTRAL
Articulos de SEDE CENTRAL
Citación
Pisapia, Pasquale; Costa, José Luis; Pepe, Francesco; Russo, Gianluca; Gragnano, Gianluca; et al.; Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021; Elsevier; Critical Reviews In Oncology Hematology; 161; 5-2021; 1-10
Compartir
Altmétricas